DAX6.668-1,8%  Dow12.773-0,9%  Euro1,3194-0,7% 
ESt502.480-1,7%  Nas2.899-1,0%  Öl116,9-1,5% 
TDax769,8-0,5%  Nikkei8.947-0,6%  Gold1.716-0,8% 

Rogers Aktie [WKN: 863178 / ISIN: US7751331015]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime Push  IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Rogers Corp.. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

ALLE Nachrichten zur Rogers Corp.

23.03.10Rogers Corporation Announces Agreement to Acquire SK Utis Co., Ltd.
16.03.10Genentech Submits Supplemental Biologics License Application for ACTEMRA® (tocilizumab) for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis
12.03.10Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer
25.02.10Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
23.02.10Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint
18.02.10Rogers Corporation Reports 2009 Fourth Quarter and Full Year Results
11.02.10Rogers Corporation Invites You to Join its 2009 Fourth Quarter and Year-End Earnings Conference Call
12.01.10Rogers Corporation Announces Three Significant Mass Transit Project Awards for its BISCO® Silicones
08.01.10Rogers Corporation to Present at CJS Securities, Inc. Tenth Annual "New Ideas for the New Year” Investor Conference
07.01.10Rogers Corporation Issues Guidance for the Full Year 2010 and Updates Sales Guidance for the Fourth Quarter of 2009
17.12.09Roche Diagnostics Licenses Melting Curve Analysis and SYBR Green Techniques to Takara Bio
16.12.09Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
02.11.09Rogers Corporation Reports 2009 Third Quarter Results
26.10.09Rogers Corporation Invites You to Join its 2009 Third Quarter Earnings Conference Call
06.10.09SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
15.09.09Rogers Corporation Raises Guidance for the Third Quarter
11.08.09Rogers Corporation to Present at CJS Securities, Inc. Ninth Annual "New Ideas” Summer Conference
03.08.09Rogers Corporation Reports 2009 Second Quarter Results
27.07.09Rogers Corporation Announces One-Time Charges and 2009 Second Quarter Conference Call
22.07.09Rogers Corporation Announces Strategic Investment in Solicore, Inc.
05.06.09Rogers Corporation Names Senior Vice Presidents
07.05.09Rogers Corporation Holds Annual Meeting of Shareholders
04.05.09Rogers Corporation Reports 2009 First Quarter Results
04.05.09Rogers Corporation Completes Acquisition of MTI Global Inc. Silicones Business Assets
27.04.09Rogers Corporation Invites You to Join its 2009 First Quarter Earnings Conference Call
24.03.09Rogers Corporation to Acquire Assets of MTI Global Inc. Silicones Business
18.02.09Rogers Corporation Reports 2008 Year-End and Fourth Quarter Results
11.02.09Rogers Corporation Invites You to Join its 2008 Year-End and Fourth Quarter Earnings Conference Call
03.02.09Rogers Corporation Announces Cost Reduction Initiative
12.01.09Rogers Corporation Updates Guidance for the Fourth Quarter
09.01.09Rogers Corporation to Present at Sidoti & Company, LLC Emerging Growth Institutional Investor Forum Conference
09.01.09Rogers Corporation Announces Agreement to Settle Dispute with CalAmp Corp.
08.01.09Plexxikon and Roche Enter Second Partnership to Develop PLX5568 for Polycystic Kidney Disease
07.01.09Synta and Roche Form Discovery, Development, and Commercialization Alliance in Inflammation
29.12.08Rogers Corporation to Present at CJS Securities, Inc. Ninth Annual "New Ideas for the New Year” Investor Conference
31.10.08Rogers Corporation Sells Its Induflex Business and Updates Fourth Quarter 2008 Guidance
29.10.08Rogers Corporation Reports 2008 Third Quarter Results
24.10.08Rogers Corporation Invites You to Join Its Third Quarter Earnings Conference Call
03.10.08Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy
30.07.08Rogers Corporation Reports 2008 Second Quarter Results

Anzeige

ANZEIGE